Skip to main content
Clinical Trials/NCT03590665
NCT03590665TerminatedNot Applicable

Central & Peripheral Blood Flow Regulations in Individuals With Down Syndrome

University of Illinois at Chicago1 site in 1 country21 target enrollmentStarted: March 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
21
Locations
1
Primary Endpoint
Brachial blood flow

Study Overview

Brief Summary

This study focuses on physiological explanations of difficulties with physical activity and exercise in individuals with Down syndrome, by non-invasively examining cardiac output and the regulation of blood flow to working muscles during exercise.

Detailed Description

Work capacity is an important predictor of declining health or physical function, and of mortality, and is commonly measured as peak oxygen consumption. Peak oxygen consumption is very low in individuals with Down syndrome, the most prevalent genetic cause of intellectual disability. Previous research suggests individuals with Down syndrome may experience a double disadvantage when they are exercising: they may not be able to increase cardiac output sufficiently and they may not be able to allocate adequate blood flow to the working muscles.

The aim of this research study is therefore to determine the impact of limitations in central and peripheral regulation of blood flow on work capacity in individuals with DS. The results of this project will aid our understanding of the underlying mechanisms and determine the potential to improve health across the lifespan of individuals with Down syndrome by tailoring exercise interventions.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Between 18 and 45 years old
  • •generally healthy
  • •sedentary or low-active (defined as being involved in less than 30 minutes of moderately-intense physical activity per day)
  • •additionally for the participants with Down syndrome:
  • •diagnosis of Down syndrome trisomy 21 and
  • •normal thyroid function or stable thyroid function (and medications) for at least 6 months.

Exclusion Criteria

  • •atherosclerotic or other vascular disease;
  • •asthma or other pulmonary disease;
  • •hypertension (defined BP >140/90 mmHg);
  • •blood pressure below 90/60 mmHg;
  • •history of pre-syncope or syncope;
  • •diabetes (defined as Hba1c of >7.5% or use of glucose lowering medication);
  • •severe obesity (defined as BMI >40);
  • •medications affecting heart rate, blood pressure or arterial function;
  • •anti-inflammatory medication including NSAIDS;
  • •current smoking and
  • •pregnancy.

Arms & Interventions

Individuals with Down syndrome

Other

For participants with Down syndrome, the first visit includes baseline measures and familiarization with the graded maximal exercise test protocol. If necessary, additional familiarization sessions will be scheduled for people with Down syndrome. The second visit, we perform the graded maximal exercise test and familiarize the participant with the procedures for the third visit: the hand grip exercise protocol and the lower body negative pressure (LBNP) box. The third visit we assess the peripheral blood flow during the hand grip exercise protocol without and with the LBNP. For control subjects, the first and second visit are combined. Their second visit is the same as the third visit for individuals with Down syndrome.

Intervention: Hand grip exercise and lower body negative pressure (Other)

Individuals without Down syndrome

Other

For participants with Down syndrome, the first visit includes baseline measures and familiarization with the graded maximal exercise test protocol. The second visit, we perform the graded maximal exercise test and familiarize the participant with the procedures for the third visit: the hand grip exercise protocol and the lower body negative pressure (LBNP) box. The third visit we assess the peripheral blood flow during the hand grip exercise protocol without and with the LBNP. For control subjects, the first and second visit are combined. Their second visit is the same as the third visit for individuals with Down syndrome.

Intervention: Hand grip exercise and lower body negative pressure (Other)

Outcomes

Primary Outcomes

Brachial blood flow

Time Frame: In minute 4 of the 5-minute bout of grip strength exercise

Forearm blood flow and vascular conductance will be measured in both the exercising and non-exercising arm using high definition ultrasound (Alpha 7, Aloka-Hitachi). The brachial artery will be imaged in dual mode allowing for simultaneous determination of artery diameter (B-mode) and flow velocity (Doppler mode). Blood flow will be determined from the following formula: Forearm Blood flow = (Mean blood velocity) x (Brachial Cross Sectional Area) x (60) and expressed as ml/min. Forearm vascular conductance will be determined by dividing forearm blood flow by mean arterial pressure. Forearm blood flow and vascular conductance will be normalized to forearm lean mass to account for differences in lean mass between individuals.

Secondary Outcomes

  • Muscle oxygenation(In minute 4 of the 5-minute bout of grip strength exercise)
  • Cardiac outut(Every second minute until the 12th minute of the maximal test.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Thessa Hilgenkamp

Postdoctoral fellow

University of Illinois at Chicago

Study Sites (1)

Loading locations...

Similar Trials